Preview: Harvard Bioscience's Earnings
Portfolio Pulse from Benzinga Insights
Harvard Bioscience (NASDAQ:HBIO) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.05. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $4.83 and has seen a 34.52% increase over the last 52-week period.
August 07, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Harvard Bioscience is expected to release its Q2 earnings report. The company has a history of beating EPS estimates, which has generally led to an increase in share price. The stock has seen a 34.52% increase over the last 52-week period.
The company's history of beating EPS estimates and the positive trend in its stock price over the last 52 weeks suggest that the upcoming earnings report could have a positive impact on the stock. However, the actual impact will depend on whether the company meets or exceeds the EPS estimate and the guidance it provides for future growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100